ArticleThoracic cancer2022

Impact of losing adipose tissue on outcomes from PD-1/PD-L1 inhibitor monotherapy in non-small cell lung cancer.

Naoya Nishioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.